Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Eniluracil by Processa Pharmaceuticals for Gastrointestinal Tumor: Likelihood of Approval
Eniluracil is under clinical development by Processa Pharmaceuticals and currently in Phase I for Gastrointestinal Tumor. According to GlobalData, Phase...
Eniluracil by Processa Pharmaceuticals for Metastatic Colorectal Cancer: Likelihood of Approval
Eniluracil is under clinical development by Processa Pharmaceuticals and currently in Phase I for Metastatic Colorectal Cancer. According to GlobalData,...
Eniluracil by Processa Pharmaceuticals for Solid Tumor: Likelihood of Approval
Eniluracil is under clinical development by Processa Pharmaceuticals and currently in Phase I for Solid Tumor. According to GlobalData, Phase...
Eniluracil by Processa Pharmaceuticals for Pancreatic Cancer: Likelihood of Approval
Eniluracil is under clinical development by Processa Pharmaceuticals and currently in Phase I for Pancreatic Cancer. According to GlobalData, Phase...